12-hydroxy-5,8,10-heptadecatrienoic acid and Hypertension

12-hydroxy-5,8,10-heptadecatrienoic acid has been researched along with Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrahám, G; Gecse, A; Kis, B; Mezei, Z; Sonkodi, S; Telegdy, G1
Gecse, A; Telegdy, G1

Other Studies

2 other study(ies) available for 12-hydroxy-5,8,10-heptadecatrienoic acid and Hypertension

ArticleYear
Platelet eicosanoids and the effect of captopril in blood pressure regulation.
    European journal of pharmacology, 1997, Dec-04, Volume: 340, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arachidonic Acid; Blood Platelets; Blood Pressure; Captopril; Eicosanoids; Fatty Acids, Unsaturated; Hypertension; Lipoxygenase; Male; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred SHR; Rats, Wistar; Thromboxanes

1997
Captopril as a modifier of the arachidonate cascade of rat platelets.
    Agents and actions. Supplements, 1992, Volume: 38 ( Pt 3)

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acids; Blood Platelets; Captopril; Dose-Response Relationship, Drug; Epoprostenol; Fatty Acids, Unsaturated; Female; Hydroxyeicosatetraenoic Acids; Hypertension; In Vitro Techniques; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Reference Values

1992